Parabilis Medicines Inc（PBLS）の株価予測PBLSParabilis Medicines Inc

Alphio's PBLS stock price prediction model matches the current Parabilis Medicines Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $25.09 (+2.67%). The 1-week path is $24.72 (+1.14%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.

Parabilis Medicines Inc (PBLS) appears to be a good buy right now due to its recent positive developments and strong analyst support. The stock is currently priced at $24.44, which is significantly below the analyst price targets of $40 from Leerink and Guggenheim, suggesting a potential upside of over 60%. Additionally, the company has shown promising efficacy data for its lead drug, zolucatetide, with a 72.2% objective response rate in a recent study, indicating strong potential for future growth. However, the main risk is the negative earnings trend, with a reported EPS of -2.13 in the last quarter, which reflects ongoing losses.

Parabilis Medicines Inc (PBLS) last closed at $24.44, losing -9.21%. These facts feed the 1-day and 1-week PBLS price prediction above.